Anthony Atala to Antineoplastic Agents
This is a "connection" page, showing publications Anthony Atala has written about Antineoplastic Agents.
Connection Strength
1.912
-
Atala A. Re: Reporter Nanoparticle that Monitors its Anticancer Efficacy in Real Time. J Urol. 2016 10; 196(4):1313-4.
Score: 0.401
-
Atala A. Re: SAHA Triggered MET Activation Contributes to SAHA Tolerance in Solid Cancer Cells. J Urol. 2015 Sep; 194(3):848-9.
Score: 0.372
-
Atala A. Re: Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. J Urol. 2015 Apr; 193(4):1441-2.
Score: 0.361
-
Atala A. Re: Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice. J Urol. 2014 Aug; 192(2):614.
Score: 0.345
-
Atala A. Re: enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated salmonella carrying a plasmid co-expressing p53 gene and MDM2 siRNA. J Urol. 2014 Mar; 191(3):866-7.
Score: 0.334
-
Atala A. Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase. J Urol. 2016 07; 196(1):280-1.
Score: 0.098